DOJ FCPA Probe Focusing on Payments in Foreign Drug Trials
The Justice Department's so-called "pharma initiative" is investigating whether drug companies conducting foreign clinical trials have paid third-party investigators to finesse research data.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10